| 12398121 |
Anti-cancer nuclear hormone receptor-targeting compounds |
David Hung, Son Minh Pham, Sarvajit Chakravarty, Jiyun Chen, Anup Barde +1 more |
2025-08-26 |
|
| 12208141 |
Anti-cancer nuclear hormone receptor-targeting compounds |
David Hung, Son Minh Pham, Sarvajit Chakravarty, Jiyun Chen, Jeremy D. Pettigrew +2 more |
2025-01-28 |
|
| 12006314 |
Anti-cancer nuclear hormone receptor-targeting compounds |
David Hung, Christopher Miller, Jeremy D. Pettigrew, Son Minh Pham, Ihab Darwish |
2024-06-11 |
$14,113,000 |
| 11952349 |
Anti-cancer nuclear hormone receptor-targeting compounds |
Son Minh Pham, Jeremy D. Pettigrew, Christopher Miller |
2024-04-09 |
$13,074,000 |
| 11834458 |
Anti-cancer nuclear hormone receptor-targeting compounds |
David Hung, Christopher Miller, Jeremy D. Pettigrew, Son Minh Pham, Ihab Darwish |
2023-12-05 |
$3,741,000 |
| 11826430 |
Anti-cancer nuclear hormone receptor-targeting compounds |
David Hung, Son Minh Pham, Sarvajit Chakravarty, Jiyun Chen, Jeremy D. Pettigrew +2 more |
2023-11-28 |
$3,539,000 |
| 11584756 |
Heterocyclic compounds as BET inhibitors |
Son Minh Pham, Sarvajit Chakravarty, Jiyun Chen, Chris P. Miller, Jeremy D. Pettigrew +2 more |
2023-02-21 |
$6,529,000 |
| 11332473 |
Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors |
Sarvajit Chakravarty, Son Minh Pham, Brahmam Pujala, Sanjeev Soni, Puja JAISWAL +2 more |
2022-05-17 |
$13,082,000 |
| 11306071 |
Heterocyclic compounds as adenosine antagonists |
Son Minh Pham, Pradeep S. Jadhavar, Baban Mohan MULIK, Farha Khan, Sreekanth A. Ramachandran |
2022-04-19 |
$17,024,000 |
| 11299493 |
Heterocyclic compounds and uses thereof |
Sarvajit Chakravarty, Son Minh Pham, Anil Kumar Agarwal, Brahmam Pujala, Sanjeev Soni +4 more |
2022-04-12 |
$17,595,000 |
| 11292782 |
Diarylhydantoin compounds and methods of use thereof |
Sarvajit Chakravarty, Son Minh Pham, Jiyun Chen, Jeremy D. Pettigrew, Anjan Kumar Nayak +2 more |
2022-04-05 |
$18,047,000 |
| 11254670 |
1,8-naphthyridinone compounds and uses thereof |
Son Minh Pham, Pradeep S. Jadhavar, Baban Mohan MULIK, Farha Khan, Sreekanth A. Ramachandran |
2022-02-22 |
$16,897,000 |
| 11192900 |
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors |
Son Minh Pham, Sarvajit Chakravarty, Jiyun Chen, Anjan Kumar Nayak, Anup Barde |
2021-12-07 |
$29,394,000 |
| 11174252 |
Heterocyclic compounds as kinase inhibitors |
Son Minh Pham, Sarvajit Chakravarty, Brahmam Pujala, Amit Shete, Bhawana Bhatt +3 more |
2021-11-16 |
$28,184,000 |
| 11034669 |
Pyrrole and pyrazole compounds and methods of use thereof |
Sarvajit Chakravarty, Son Minh Pham, Jiyun Chen, Jeremy D. Pettigrew, Anjan Kumar Nayak +2 more |
2021-06-15 |
$31,437,000 |
| 10807994 |
Heterocyclic compounds and uses thereof |
Sarvajit Chakravarty, Son Minh Pham, Anil Kumar Agarwal, Brahmam Pujala, Sanjeev Soni +3 more |
2020-10-20 |
$1,976,000 |
| 10617706 |
Compounds for cancer chemotherapeutic sensitization |
Zhengqiang Wang, Yves G. Pommier |
2020-04-14 |
|